Bio-Thera Solutions
Manufacturing · China · 201-500 Employees
View Company Info for Free
Overview
Headquarters
11 Kai-yuan Science City Blvd, Guangzhou...Website
www.bio-thera.comRevenue
$13.7 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Bio-Thera Solutions
Biotech Therapeutics Co., Ltd. is a global biopharmaceutical company based in Guangzhou, China, focused on the development of next-generation antibody drugs for the treatment of cancer, autoimmune diseases, cardiovascular diseases, and other major health threats. The company offers several marketed products, including the first domestically produced adalimumab injection, and adheres to a quality management system compliant with GMP standards in the US, EU, and China. With a commitment to innovation aimed at addressing urgent clinical needs, Biotech Therapeutics actively collaborates with partners to expand its market presence, particularly in Southeast Asia. The company is publicly traded on the Shanghai Stock Exchange under the code 688177.Explore more
Bio-Thera Solutions Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Bio-Thera Solutions your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Bio-Thera Solutions has new funding data
Check out if Bio-Thera Solutions is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Bio-Thera Solutions
Check if Bio-Thera Solutions has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Bio-Thera Solutions had a recent Job posting/layoffs
Bio-Thera Solutions, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Bio-Thera Solutions recently announced quarterly report
Product Launch: Get notified when Bio-Thera Solutions launches new products
Recommended Actions
Find VP level buyers at Bio-Thera Solutions
Find more new buyers
Company Profile Activity
Activity Insights
Bio-Thera Solutions is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Bio-Thera Solutions is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Bio-Thera Solutions.
Bio-Thera Solutions financials insights
Gather financial insights about Bio-Thera Solutions, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Stock Offering
$241M
Bio-Thera Solutions Tech Stack
A closer look at the technologies used by Bio-Thera Solutions
See more technologies
Most Recent Scoops
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Event
Product Marketing, Events, Training, Sales, Logistics / Supply Chain, Pharmaceuticals, Clinical Operations, Field Marketing, Manufacturing Operations, Operations
Bio-Thera Solutions News & Media
Bio-Thera Solutions' Golimumab Biosimilars Receive FDA Approval as First Biosimilars to Simponi® and Simponi Aria®; Accord BioPharma to Commercialize IMMGOLIS™ (golimumab-sldi) and IMMGOLIS INTRI™ (golimumab-sldi) in the United States
GUANGZHOU, China, May 18, 2026 /PRNewswire/ -- Bio-Thera Solutions (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars, and Accord BioPharma, Inc, the U.S. specialty division of Intas Pharmaceuticals, Ltd. ("Intas"),...Bio-Thera Solutions Announces Further Expansion of Partnership with Intas Pharmaceuticals for BAT2506, a Proposed Biosimilar Referencing Simponi® (golimumab), through Exclusive Commercialization and License Agreement in India
GUANGZHOU, China, March 23, 2026 /PRNewswire/ -- Bio-Thera Solutions (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars, today announced a further expansion of its partnership with Intas Pharmaceuticals for BAT2506, a...STADA and Bio-Thera receive European Marketing Authorization for Gotenfia, a Biosimilar to Simponi
European Commission grants approval for Gotenfia®, a golimumab biosimilar to Simponi® that was developed by Bio-Thera and will be marketed by STADA Launch preparations are underway to bring the second approved golimumab biosimilar to patients across Europe in the coming weeks and months...Golimumab biosimilar Gotenfia from STADA and Bio-Thera receives positive CHMP opinion
Positive opinion from European Medicines Agency supports approval for golimumab biosimilar Gotenfia® developed by Bio-Thera and to be marketed by STADA Recommendation from EMA's CHMP committee is based on a robust analytical, non-clinical and clinical data package comparing the biosimilar...
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Bio-Thera Solutions
Sign Up For FreeTo access detailed company insights
Biotech Therapeutics Co., Ltd. is a global biopharmaceutical company based in Guangzhou, China, focused on the development of next-generation antibody drugs for the treatment of cancer, autoimmune diseases, cardiovascular diseases, and other major health threats. The company offers several marketed products, including the first domestically produce... Read More
